CIK 0000886744 · Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752287752
- Phone
- 6504737700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,540 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 13,300 shares at $1.18 ($15,667)
- 4 Grant or award Director acquired 4,913 shares (grant or award)
- 4/A Grant or award Director acquired 2,206 shares (grant or award)
- 4/A Grant or award Director acquired 1,767 shares (grant or award)
- 4/A Grant or award Director acquired 4,378 shares (grant or award)
- 4 Open-market buy EVP, Chief Legal Officer bought 15,000 shares at $1.61 ($24,150)
- 4 Open-market buy Chairman, President and CEO bought 12,500 shares at $1.77 ($22,063)
- 4 Open-market buy EVP, Chief Commercial Officer bought 100,000 shares at $1.60 ($160,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 35 · 690 filings